Among adults with obesity who lost weight after following a low-calorie diet, weight-loss maintenance with exercise was ...
GSK plc (NYSE:GSK) plc Bank of America Global Healthcare Conference 2025 September 24, 2025 4:00 AM EDTCompany ParticipantsJulie Brown - CFO & ...
AstraZeneca and Daiichi Sankyo’s supplemental Biologics License Application for Enhertu plus pertuzumab has been accepted for Priority Review b ...
In view of persistent fever and cough, and the new onset of an accentuated confluent maculopapular rash, the patient was ...
Clinical Trials Arena on MSN
Imunon’s IL-12 gene therapy changes “cold” tumour microenvironment to “hot”
Translational results bolster confidence as Phase III trial for IMNN-001 in advance epithelial ovarian cancer gets underway.
India - Grant Romiplostim Lyophilized Formulations Patent With Amendments: Madras High Court Directs. Legal News and Analysis ...
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have rapidly emerged as highly effective pharmacological tools for ...
Icotrokinra demonstrated superior skin clearance at Weeks 16 and 24 compared to deucravacitinib and similar adverse event ...
NEWARK, CALIFORNIA / ACCESS Newswire / September 15, 2025 / Protagonist Therapeutics, Inc. (“Protagonist” or the “Company”) ...
DelveInsight’s “Atopic Dermatitis Pipeline Insight 2025” report provides comprehensive insights about 100+ companies and 120+ ...
Zacks Investment Research on MSN
BDTX vs. Cullinan Therapeutic: Which EGFR Challenger Is the Better Buy?
Black Diamond Therapeutics, Inc. (BDTX) is a clinical-stage oncology company developing therapies that target families of ...
DelveInsight's Prurigo Nodularis Market Insights report includes a comprehensive understanding of current treatment practices ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results